Statement From the Consumer Healthcare Products Association on Today's FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose
Posted on: Friday, 14 December 2007, 18:00 CST
WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the recommendations of the U.S. Food and Drug Administration's Nonprescription Drugs Advisory Committee on phenylephrine:
"Phenylephrine 10 mg is safe when used according to the label and has been proven effective for nasal decongestion in multiple clinical trials. Today, the FDA's expert panel voted almost unanimously [11-1] that the existing evidence supports the effectiveness of phenylephrine at the 10 mg dose and reaffirms the results of numerous scientific studies and decades of consumer experience.
"CHPA and the leading makers of OTC cough, cold, and allergy medicines containing phenylephrine are committed to adding to the existing body of evidence currently supporting the safety and efficacy of phenylephrine. Our goal is to continue to provide consumers with safe and effective therapies, and we are committed to working with FDA to ensure that the scientific data further supports this goal.
"Consumers should remain confident that phenylephrine 10mg provides safe and effective relief from nasal congestion due to the common cold and allergies and that this FDA-approved nasal decongestant will remain conveniently available over-the-counter.
"For over forty years, consumers worldwide have relied upon phenylephrine to give them much needed relief from nasal congestion caused by the common cold and allergies. We look forward to working with FDA staff as they review the recommendations of today's panel. We will continue our commitment to ensure that consumers have access to safe and effective over-the-counter therapies.
CHPA is the 126-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.
http://www.chpa-info.org/
Consumer Healthcare Products Association
CONTACT: Elizabeth Funderburk or Virginia Cox, +1-202-429-9260, both ofthe Consumer Healthcare Products Association
Web Site: http://www.chpa-info.org/
Source: PRNewswire-USNewswire
Related Articles
- Federal Trade Commission Reports: Authorized Generics, During the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
- Audio Conference on Consumer-Centric Approaches in Healthcare: How to Drive Patient Satisfaction and Bottom Line Revenues
- High Growth Forecasted for the Natural and Organic Food and Beverage Trends: Current and Future Patterns in Production, Marketing, Retailing, and Consumer Usage, 2nd Edition
- WorldDoc, Inc. Partners With HealthGrades, Inc. To Help Consumers Find the Best Healthcare Providers Using Independent Quality Ratings
- Product Innovations and Increasing Consumer Purchasing Power Propel Growth in the Brazilian Flavours Market
- CONSUMERS, CHARACTERS, AND PRODUCTS: A Balance Model of Sitcom Product Placement Effects
- Partnership for Safe Medicines Offers Consumers Tools to Protect Families From Counterfeit Drugs
- American Garden Launches "Bring Home the Garden"TM, a New Brand Identity to Bring Its Products Closer to Its Consumers.
- Partnership for Safe Medicines Offers Consumer Tips to Identify and Protect Against Counterfeit Drugs
- American Consumers Have Variety of Domestic Options for Savings on Safe, Effective Prescription Drugs
 |
 |
User Comments (0)
RSS Feeds